• 127 引文
  • 7 h-指數
20132020

每年研究成果

如果您對這些純文本內容做了任何改變,很快就會看到。

研究成果

  • 127 引文
  • 7 h-指數
  • 25 文章
2020

Comparative effectiveness and costeffectiveness of three first-line EGFR-tyrosine kinase inhibitors: Analysis of real-world data in a tertiary hospital in Taiwan

Yang, S. C., Lai, W. W., Hsu, J. C., Su, W. C. & Wang, J. D., 四月 2020, 於 : PLoS ONE. 15, 4, e0231413.

研究成果: 雜誌貢獻文章

開啟存取

Health inequality: A longitudinal study on geographic variations in lung cancer incidence and mortality in Taiwan

Hsu, J. C., Tseng, Y. C., Chang, S. M., Lee, Y. C., Lin, P. C. & Chu, H. J., 六月 17 2020, 於 : BMC Public Health. 20, 1, 951.

研究成果: 雜誌貢獻文章

開啟存取

Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: An interrupted time series study

Hsu, J. C., Wei, C. F., Yang, S. C., Lin, P. C., Lee, Y. C. & Lu, C. Y., 五月 10 2020, 於 : BMJ Open. 10, 5, e033427.

研究成果: 雜誌貢獻文章

開啟存取
2019

Budget impact analysis of osteoporosis medications for primary prevention of fractures in Taiwan

Wu, K. L., Wu, C. H., Chang, Y. F., Lin, Y. T. & Hsu, J. C., 一月 1 2019, (接受/付印) 於 : Journal of Bone and Mineral Metabolism.

研究成果: 雜誌貢獻文章

開啟存取
開啟存取
2 引文 斯高帕斯(Scopus)
2018

Disease and economic burden for rare diseases in Taiwan: A longitudinal study using Taiwan’s National Health Insurance Research Database

Hsu, J. C., Wu, H. C., Feng, W. C., Chou, C. H., Lai, E. C. C. & Lu, C. Y., 九月 2018, 於 : PLoS ONE. 13, 9, e0204206.

研究成果: 雜誌貢獻文章

開啟存取
6 引文 斯高帕斯(Scopus)

Effectiveness and safety of immune checkpoint inhibitors: A retrospective study in Taiwan

Hsu, J. C., Lin, J. Y., Hsu, M. Y. & Lin, P. C., 八月 2018, 於 : PLoS ONE. 13, 8, e0202725.

研究成果: 雜誌貢獻文章

開啟存取
1 引文 斯高帕斯(Scopus)

Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization

Chen, H-Y., Chiu, P. Y., Chang, C. J., Tsai, L. L., Huang, Y. L. & Hsu, J. C., 十二月 1 2018, 於 : Clinical Drug Investigation. 38, 12, p. 1125-1133 9 p.

研究成果: 雜誌貢獻文章

2 引文 斯高帕斯(Scopus)

Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan

Hsu, J. C., Su, Y. C., Tang, B. Y. & Lu, C. Y., 十一月 2018, 於 : PLoS ONE. 13, 11, e0206208.

研究成果: 雜誌貢獻文章

開啟存取
2 引文 斯高帕斯(Scopus)
2017

10-year trends in statin utilization in Taiwan: A retrospective study using Taiwan's National Health Insurance Research Database

Hsieh, H. C., Hsu, J. C. & Lu, C. Y., 五月 1 2017, 於 : BMJ Open. 7, 5, e014150.

研究成果: 雜誌貢獻文章

開啟存取
16 引文 斯高帕斯(Scopus)

Geographic Variations and Time Trends in Cancer Treatments in Taiwan

Hsu, J. C., Chang, S. M. & Lu, C. Y., 八月 2 2017, 於 : BMC Public Health. 18, 1, 89.

研究成果: 雜誌貢獻文章

開啟存取
3 引文 斯高帕斯(Scopus)

Trend and geographic analysis of the prevalence of dengue in Taiwan, 2010–2015

Hsu, J. C., Hsieh, C. L. & Lu, C. Y., 一月 1 2017, 於 : International Journal of Infectious Diseases. 54, p. 43-49 7 p.

研究成果: 雜誌貢獻文章

開啟存取
14 引文 斯高帕斯(Scopus)
2016
開啟存取
8 引文 斯高帕斯(Scopus)

Longitudinal trends in use of targeted therapies for treatment of malignant neoplasms of the eye: a population-based study in Taiwan

Hsu, J. C., Gonzalez-Gonzalez, L. A., Lu, V. H. & Lu, C. Y., 五月 27 2016, 於 : BMJ Open. 6, 5, p. e010706

研究成果: 雜誌貢獻文章

開啟存取
2 引文 斯高帕斯(Scopus)
2015

Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan

Hsu, J. C., Cheng, C. L., Ross-Degnan, D., Wagner, A. K., Zhang, F., Kao Yang, Y. H., Liu, L. L., Tai, H. Y., Chen, K. H., Yang, P. W. & Lu, C. Y., 十月 1 2015, 於 : Pharmacoepidemiology and Drug Safety. 24, 10, p. 1026-1035 10 p.

研究成果: 雜誌貢獻文章

5 引文 斯高帕斯(Scopus)

How Did Multiple FDA Actions Affect the Utilization and Reimbursed Costs of Thiazolidinediones in US Medicaid?

Hsu, J. C., Ross-Degnan, D., Wagner, A. K., Zhang, F. & Lu, C. Y., 七月 21 2015, 於 : Clinical Therapeutics. 37, 7, p. 1420-1432.e1

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)

Net clinical benefit of oral anticoagulants: A multiple criteria decision analysis

Hsu, J. C., Hsieh, C. Y., Yang, Y. H. K. & Lu, C. Y., 四月 21 2015, 於 : PLoS ONE. 10, 4, e0124806.

研究成果: 雜誌貢獻文章

開啟存取
14 引文 斯高帕斯(Scopus)
5 引文 斯高帕斯(Scopus)
開啟存取
12 引文 斯高帕斯(Scopus)

Utilization of oral antidiabetic medications in Taiwan following strategies to promote access to medicines for chronic diseases in community pharmacies

Hsu, J. C., Ross-Degnan, D., Wagner, A. K., Cheng, C. L., Yang, Y. H. K., Zhang, F. & Lu, C. Y., 一月 1 2015, 於 : Journal of Pharmaceutical Policy and Practice. 8, 1, p. 1-9 9 p., 15.

研究成果: 雜誌貢獻文章

開啟存取
7 引文 斯高帕斯(Scopus)
2014

Impacts of drug reimbursement reductions on utilization and expenditures of oral antidiabetic medications in Taiwan: An interrupted time series study

Hsu, J. C., Lu, C. Y., Wagner, A. K., Chan, K. A., Lai, M. S. & Ross-Degnan, D., 六月 2014, 於 : Health Policy. 116, 2-3, p. 196-205 10 p.

研究成果: 雜誌貢獻文章

12 引文 斯高帕斯(Scopus)

Utilization patterns of antihyperuricemic agents following safety announcement on allopurinol and benzbromarone by Taiwan Food and Drug Administration

Cheng, C. L., Chao, P. H., Hsu, J. C. H. S., Weng, M. M. E. Y., On, A. W. F. & Yang, Y. H. K. A., 三月 1 2014, 於 : Pharmacoepidemiology and Drug Safety. 23, 3, p. 309-313 5 p.

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)
2013
2 引文 斯高帕斯(Scopus)